Tumor characteristics (burden)-High Tumor Burden Posts on Medivizor
Navigation Menu

Tumor characteristics (burden)-High Tumor Burden Posts on Medivizor

Evaluating outcomes for patients with follicular lymphoma after rituximab maintenance therapy

Posted by on Aug 4, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at long-term outcomes for patients with follicular lymphoma after rituximab (Rituxan) maintenance therapy. This study concluded that rituximab maintenance helped improve long-term survival without disease progression compared to no treatment. Some background Follicular lymphoma (FL) is the second most common type of...

Read More

Evaluating lenalidomide plus R-CHOP in patients with high tumor burden follicular lymphoma

Posted by on Oct 5, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of lenalidomide (Revlimid) plus R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy in previously untreated patients with follicular lymphoma (FL) and a high tumor burden (a large number of cancer cells or tumors in the body). This study concluded that...

Read More